CCND2 and prostate carcinoma: This genetic study implicates the association of the SNPs rs3217869 (CCND2) and rs12643184 (PDGF-C), and the genes BAD, PDGF-D and CCND2 in the RTK/ERK signaling pathway with aggressive prostate cancer.